However, knockout ERK5 in TAMs reduces the phosphorylation of STAT3 and inhibits its M2 phenotype, which promotes the anti-tumor activity of TAMs, thereby inhibiting the melanoma growth (161), which suggests that targeting ERK5 is an attractive cancer treatment strategy. The gene discussed is MAPK7; the disease is melanoma.